Lenvatinib plus pembro for aRCC - update on the CLEAR study

Abemaciclib plus NSAI for HR+, HER2- advanced breast cancer - MONARCH 3 interim data

Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial

Atezolizumab improves on single-agent chemo for NSCLC not eligible for platinum-containing regimen

A new era of early cancer detection with blood test may change cancer screening paradigms

Optimum treatment strategy algorithm for mCRC

Working to improve global cancer care access in low middle-income countries

Physical activity improves quality of life for patients with pancreatic cancer

Lung cancer immunotherapy adjuvant and neoadjuvant indications

War in Ukraine: Global cancer aid to support refugees

The abscopal effect of radiotherapy and nivolumab in relapsed or refractory Hodgkin lymphoma

Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients